SCHEMBL21101401

SCHEMBL21101401

CCOC(=O)c1c[nH]c2c(Br)cccc2c1=O

nearest known ligand 0.78

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CLEC4M Q9H2X3 1/20 0.78
KDM4E B2RXH2 4/20 0.68
GABRA1 P14867 3/20 0.58
GABRB2 P47870 3/20 0.58
GABRB1 P18505 2/20 0.58
GABRA3 P34903 2/20 0.58
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2C19 P33261 1/20 0.57
MAPT P10636 1/20 0.57
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
MAOB P27338 1/20 0.47
TP53 P04637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11195138 0.94 CLEC4M (0.76) CLEC4MKDM4EGABRA1GABRB2GABRB1
SCHEMBL28287784 0.86 CLEC4M (0.82) CLEC4MKDM4EGABRA1GABRB2GABRB1
SCHEMBL1244789 0.85 CLEC4M (0.80) CLEC4MKDM4EGABRA1GABRB2GABRB1
SCHEMBL22492440 0.85 CLEC4M (0.80) CLEC4MKDM4EGABRA1GABRB2GABRB1
SCHEMBL16341803 0.84 CLEC4M (0.78) CLEC4MKDM4EGABRA1GABRB2GABRB1
SCHEMBL1126279 0.84 CLEC4M (0.78) CLEC4MKDM4EGABRA1GABRB2GABRB1
SCHEMBL11195663 0.84 CLEC4M (0.78) CLEC4MKDM4EGABRA1GABRB2GABRB1
SCHEMBL774558 0.83 CLEC4M (0.76) CLEC4MKDM4EGABRA1GABRB2GABRB1
SCHEMBL5133700 0.83 CLEC4M (0.71) CLEC4MKDM4EGABRA1GABRB2GABRB1
SCHEMBL28289147 0.82 CLEC4M (0.74) CLEC4MKDM4EGABRA1GABRB2GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111448192-B Process for preparing anthelmintic 4-amino-quinoline-3-carboxamide derivatives 拜耳动物保健有限责任公司 2024-04-12 CN disclosed
US-11505544-B2 Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives BAYER ANIMAL HEALTH GMBH (DE) 2022-11-22 US disclosed
US-20200308153-A1 PROCESS FOR PREPARING ANTIHELMINTIC 4-AMINO-QUINOLINE-3-CARBOXAMIDE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2020-10-01 US disclosed
US-20200308153-A1 PROCESS FOR PREPARING ANTIHELMINTIC 4-AMINO-QUINOLINE-3-CARBOXAMIDE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2020-10-01 US disclosed
CN-111448192-A Process for preparing anthelmintic 4-amino-quinoline-3-carboxamide derivatives 拜耳动物保健有限责任公司 2020-07-24 CN disclosed
WO-2019115768-A1 PROCESS FOR PREPARING ANTIHELMINTIC 4-AMINO-QUINOLINE-3-CARBOXAMIDE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2019-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11505544-B2 Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives HRH4, HRH2, HRH1 CLEC4M 2670/4885KDM4E 666/4885GABRA1 2162/4885
US-20200308153-A1 PROCESS FOR PREPARING ANTIHELMINTIC 4-AMINO-QUINOLINE-3-CARBOXAMIDE DERIVATIVES HRH4, HRH2, HRH1 CLEC4M 2670/4885KDM4E 666/4885GABRA1 2162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.